KMT2D and metabolic dysfunction-associated steatohepatitis: Mll4-AKO and control Mll4f/f littermates were then subjected to MCDD for 4 weeks (Fig. 4A), expecting that NASH resistance in Mll4-AKO would be similar to that in Mll4+/− mice.